IRIS - Res&Arch Institutional Research Information System - Research & Archive

FANELLI, Carmine Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.308
EU - Europa 4.213
AS - Asia 3.864
SA - Sud America 647
AF - Africa 101
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.163
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.188
SG - Singapore 1.983
IE - Irlanda 598
UA - Ucraina 588
RU - Federazione Russa 576
CN - Cina 541
IT - Italia 529
SE - Svezia 527
BR - Brasile 514
HK - Hong Kong 413
DE - Germania 355
FR - Francia 331
VN - Vietnam 326
FI - Finlandia 224
GB - Regno Unito 146
KR - Corea 96
IN - India 91
ES - Italia 81
TR - Turchia 70
PL - Polonia 53
AT - Austria 52
CA - Canada 52
BD - Bangladesh 50
AR - Argentina 49
MX - Messico 46
JP - Giappone 44
IQ - Iraq 40
ZA - Sudafrica 40
NL - Olanda 35
UZ - Uzbekistan 31
PK - Pakistan 24
ID - Indonesia 22
CH - Svizzera 21
AU - Australia 20
SA - Arabia Saudita 20
CO - Colombia 17
CZ - Repubblica Ceca 17
PH - Filippine 17
EC - Ecuador 16
BE - Belgio 15
MA - Marocco 15
VE - Venezuela 15
GR - Grecia 12
JO - Giordania 12
PE - Perù 11
KE - Kenya 10
MY - Malesia 10
LB - Libano 9
NP - Nepal 9
AZ - Azerbaigian 8
LT - Lituania 8
CL - Cile 7
KZ - Kazakistan 7
PY - Paraguay 7
RO - Romania 7
TN - Tunisia 7
BO - Bolivia 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
EG - Egitto 5
IL - Israele 5
OM - Oman 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BH - Bahrain 3
CI - Costa d'Avorio 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BY - Bielorussia 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
IM - Isola di Man 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
PA - Panama 2
SI - Slovenia 2
SN - Senegal 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
Totale 14.142
Salva come PNG Salva come JPEG
Città #
Singapore 1.405
Chandler 684
Dublin 598
San Jose 557
Hong Kong 406
San Mateo 346
Ashburn 319
Boardman 277
Jacksonville 270
Santa Clara 201
Altamura 192
Medford 171
Princeton 169
Moscow 164
Lauterbourg 155
Wilmington 144
Beijing 132
Lawrence 129
Perugia 120
Munich 117
Seoul 93
New York 89
Ann Arbor 88
Des Moines 88
Dong Ket 85
Los Angeles 82
Andover 78
Helsinki 76
Ho Chi Minh City 68
Saint Petersburg 53
Frankfurt am Main 51
São Paulo 50
The Dalles 50
Valencia 50
Hanoi 45
Piscataway 40
Tokyo 37
Brooklyn 35
Falls Church 35
Rome 34
Chicago 31
Warsaw 31
Izmir 28
Woodbridge 27
Norwalk 25
Nuremberg 25
Orem 24
Stockholm 24
Vienna 23
Tashkent 22
Amsterdam 20
Turku 20
Montreal 19
Dallas 18
London 17
Baghdad 16
Fremont 16
Milan 16
San Francisco 16
Amelia 15
Ankara 15
Da Nang 15
San Paolo di Civitate 15
Falkenstein 14
Redmond 14
Rio de Janeiro 14
Brussels 13
Istanbul 13
Amman 12
Denver 12
Haiphong 12
Johannesburg 12
Mexico City 12
Atlanta 11
Brno 11
Shanghai 11
Toronto 11
Auburn Hills 10
Belo Horizonte 10
Boston 10
Chennai 10
Council Bluffs 10
Poplar 10
Roubaix 10
Buenos Aires 9
Campinas 9
Curitiba 9
Goiânia 9
Guayaquil 9
Houston 9
Mumbai 9
Porto Alegre 9
Bolton 8
Brasília 8
Lima 8
Nairobi 8
Baku 7
Bexley 7
Columbus 7
Cáceres 7
Totale 8.635
Salva come PNG Salva come JPEG
Nome #
Adrenaline vs glucagon in the primacy of glucose counterregulation 173
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 168
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 156
Hypoglycemia 150
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 149
Physical activity habits and well-being among 6-year-old children: The “improving umbrian kids’ healthy lifestyle”, an uncontrolled pilot study project 143
An intensive lifestyle intervention in children with attention-deficit/hyperactivity disorder 138
18. Insulin required for prandial ghrelin suppression in humans 134
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 134
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes 132
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 124
A novel surrogate index for hepatic insulin resistance. 122
Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents 121
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 121
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia 119
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 119
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 118
Cognitive function in hypoglycaemia 116
Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes 116
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 115
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 115
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 115
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 114
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 113
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 111
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 110
Adrenergic mechanisms do not contribute to glucose counterregulation during acute insulin-induced hypoglycaemia in normal man. 110
Physical activity level and mediterranean diet adherence evaluation in older people - observational, uncontrolled, pilot study 110
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 108
IMPACT OF NOCTURNAL HYPOGLYCEMIA ON HYPOGLYCEMIC COGNITIVE DYSFUNCTION IN TYPE 1 DIABETES 107
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 107
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 107
Insulin is required for prandial ghrelin suppression in humans 106
Evaluation of maximum oxygen consumption in obese adolescents before and after a multidisciplinary lifestyle intervention 105
Are three months multidisciplinary lifestyle intervention enough to get benefits on blood pressure in overweight/obese adults ? 103
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 101
Early improvement of glucose tolerance after ileal transposition in a nonobese Type 2 diabetes rat model. 100
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 100
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 99
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 98
Effects of a supervised nordic walking program on obese adults with and without type 2 diabetes: The C.U.R.I.A.Mo. Centre experience 98
Nocturnal blood glucose control in type I diabetes mellitus. 97
Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. 96
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 96
Body composition and common carotid artery remodeling in a healthy population 94
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 94
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 93
Glucagon: the effects of its excess and deficiency on insulin action 93
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 93
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 93
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 91
Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes 91
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 91
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity 90
Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. 90
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 90
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 90
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 90
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 89
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans. 89
Impact of BMI, Physical Activity, and Sitting Time Levels on Health-Related Outcomes in a Group of Overweight and Obese Adults with and without Type 2 Diabetes 88
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 87
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 87
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 87
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 86
Premeal Insulin Treatment During Basal-Bolus Regimen in Young Children With Type 1 Diabetes 86
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative Review 84
Ipoglicemia: cause e prevenzione 83
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 83
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 83
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 82
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 81
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 81
Counterregulatory responses in CSII 80
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 80
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 80
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 80
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 80
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 79
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 79
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. 78
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 78
A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes 78
Is physical activity a necessary element during Italian coronavirus disease emergency? Yes or no debate 78
"Strength gains in different age groups of overweight/obese adults: A pilot uncontrolled study" 77
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 77
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 76
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus 75
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 75
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 73
Responses to hypoglycemia in diabetic autonomic neuropathy. 73
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 72
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 72
Obesity and carotid artery remodeling 72
Insulin therapy and hypoglycemia: the size of the problem 71
Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. 71
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. 71
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 70
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 70
Recovery and prevention of hypoglycaemia unawareness in Type 1 diabetes mellitus 70
Totale 9.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 0 0 0 0 58 103 117
2021/20221.282 29 233 30 83 34 20 20 407 16 32 137 241
2022/20232.310 184 465 31 191 170 287 5 95 788 3 67 24
2023/2024982 54 105 43 33 8 8 195 14 77 39 185 221
2024/20252.340 36 230 81 126 366 65 59 182 513 167 304 211
2025/20265.128 360 325 266 603 779 408 1.004 280 738 365 0 0
Totale 14.483